ArticleScientific reports2026
Integrated morphological, molecular, histological, and antimicrobial analysis of the leather leaf slug Eleutherocaulis alte from Assiut Governorate, Egypt.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The leatherleaf slug Eleutherocaulis alte from Assiut Governorate, Egypt, was investigated using an integrative approach combining morphological, molecular, histological, and bioactivity analyses. Morphological characterization revealed a dorsoventrally flattened body with a brown dorsal surface marked by a pale median line, dark spots, and a narrow central foot. Mitochondrial cytochrome c oxidase I (COI) gene sequencing confirmed its identity as E. alte, showing 98.23% similarity to Laevicaulis alte, and the sequence was deposited in GenBank (OR162029). Scanning electron microscopy demonstrated porous mucus-secreting surfaces essential for locomotion and adhesion, while histological examination revealed distinct secretory cell types within the epidermal and subepidermal layers, including a suprapedal gland producing mixed acidic and neutral mucopolysaccharides. Bioactivity assays indicated that the crude mucus exhibited potent antimicrobial activity, particularly against Bacillus subtilis and Candida albicans, with minimum inhibitory concentrations of 7.8 µg/mL and 3.9 µg/mL, respectively. The crude mucus showed significantly greater antimicrobial activity against Gram-positive and Gram-negative bacteria as well as C. albicans compared to the corresponding positive controls (gentamicin or fluconazole; P < 0.05 - 0.001). However, it exhibited no inhibitory effect against Aspergillus niger, collectively, these findings provide novel taxonomic, anatomical, and biomedical insights into E. alte, and highlight its mucus as a promising natural source of antimicrobial agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.